PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $971 | +15.5% | 31,641 | +50.8% | 0.08% | +4.2% |
Q2 2023 | $841 | +10.2% | 20,977 | +12.2% | 0.07% | 0.0% |
Q1 2023 | $763 | +37.5% | 18,694 | +30.0% | 0.07% | +12.5% |
Q4 2022 | $555 | -99.9% | 14,381 | +6.3% | 0.06% | -28.1% |
Q3 2022 | $720,000 | -3.7% | 13,529 | +5.5% | 0.09% | 0.0% |
Q2 2022 | $748,000 | -23.0% | 12,827 | +0.7% | 0.09% | -13.6% |
Q1 2022 | $972,000 | +28.6% | 12,742 | +1.4% | 0.10% | +24.1% |
Q4 2021 | $756,000 | +99.5% | 12,564 | +85.7% | 0.08% | +48.2% |
Q3 2021 | $379,000 | – | 6,766 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |